Cargando…

The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease

BACKGROUND: The triglyceride-glucose (TyG) index has been suggested as a dependable indicator for predicting major adverse cardiovascular events (MACE) in individuals with cardiovascular conditions. Nevertheless, there is insufficient data on the predictive significance of the TyG index in end-stage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Enmin, Ye, Zixiang, Wu, Yaxin, Zhao, Xuecheng, Li, Yike, Shen, Nan, Gao, Yanxiang, Zheng, Jingang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612201/ https://www.ncbi.nlm.nih.gov/pubmed/37891651 http://dx.doi.org/10.1186/s12933-023-02028-7

Ejemplares similares

Association of triglyceride–glucose index with coronary severity and mortality in patients on dialysis with coronary artery disease
por: Xie, Enmin, et al.
Publicado: (2023)

Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit
por: Ye, Zixiang, et al.
Publicado: (2023)

The triglyceride glucose index is associated with future cardiovascular disease nonlinearly in middle-aged and elderly Chinese adults
por: Ye, Zixiang, et al.
Publicado: (2022)

Predictive value of the stress hyperglycemia ratio in dialysis patients with acute coronary syndrome: insights from a multi-center observational study
por: Xie, Enmin, et al.
Publicado: (2023)

Triglyceride glucose index exacerbates the risk of future cardiovascular disease due to diabetes: evidence from the China Health and Retirement Longitudinal Survey (CHARLS)
por: Ye, Zixiang, et al.
Publicado: (2022)

The prediction of in-hospital mortality in chronic kidney disease patients with coronary artery disease using machine learning models
por: Ye, Zixiang, et al.
Publicado: (2023)

Effects of Metformin on COVID-19 Patients with Type 2 Diabetes: A Retrospective Study
por: Guo, Ziyu, et al.
Publicado: (2023)

Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease
por: Ye, Zixiang, et al.
Publicado: (2022)

Evaluating the predictive value of diabetes mellitus diagnosed according to the Chinese guidelines (2020 edition) for cardiovascular events
por: Ye, Zixiang, et al.
Publicado: (2022)

Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials
por: Li, Yike, et al.
Publicado: (2023)

Canada acute coronary syndrome risk score predicts no-/slow-reflow in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Xie, Enmin, et al.
Publicado: (2023)

Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension
por: Tao, Shiyi, et al.
Publicado: (2023)

Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease
por: Wu, Yaxin, et al.
Publicado: (2022)

Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes
por: Tai, Shi, et al.
Publicado: (2022)

Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice
por: Tu, Yimin, et al.
Publicado: (2022)

Triglyceride and Glucose Index and Sex Differences in Relation to Major Adverse Cardiovascular Events in Hypertensive Patients Without Diabetes
por: Yang, Kun, et al.
Publicado: (2021)

Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome
por: Wang, Le, et al.
Publicado: (2020)

Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study
por: Wu, Zhenguo, et al.
Publicado: (2022)

Influence of the Triglyceride-Glucose Index on Adverse Cardiovascular and Cerebrovascular Events in Prediabetic Patients With Acute Coronary Syndrome
por: Guo, Qianyun, et al.
Publicado: (2022)

Triglyceride-glucose index on risk of adverse events after drug-coated balloon angioplasty
por: Lin, Zhaorong, et al.
Publicado: (2023)

Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Luo, Jin-Wen, et al.
Publicado: (2021)

The Triglyceride-Glucose Index Can Predict Long-Term Major Adverse Cardiovascular Events in Turkish Patients With High Cardiovascular Risk
por: Hayıroğlu, Mert İlker, et al.
Publicado: (2022)

Triglyceride–glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension
por: Liu, Yahui, et al.
Publicado: (2023)

The Association of Triglyceride Glucose index for Coronary Artery Disease in Postmenopausal Women
por: Liu, Jingyi, et al.
Publicado: (2022)

Association between the triglyceride–glucose index and severity of coronary artery disease
por: Wang, Xiang, et al.
Publicado: (2022)

The Triglyceride-Glucose Index and Obesity-Related Risk of End-Stage Kidney Disease in Austrian Adults
por: Fritz, Josef, et al.
Publicado: (2021)

Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients
por: Alizargar, Javad, et al.
Publicado: (2020)

Triglyceride-Glucose Index and Cardiovascular Events in Kidney Transplant Recipients
por: Colladant, Mathilde, et al.
Publicado: (2023)

Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
por: Quiroga, Borja, et al.
Publicado: (2022)

Triglyceride−glucose index in the prediction of major adverse cardiovascular events in patients with type 2 diabetes mellitus after coronary artery bypass surgery: A retrospective cohort study
por: Zhang, He, et al.
Publicado: (2022)

Triglyceride glucose index is associated with obstructive coronary artery disease in hypertensive patients
por: Pan, Weili, et al.
Publicado: (2023)

Sex difference in the association of the triglyceride glucose index with obstructive coronary artery disease
por: Lu, Ya-Wen, et al.
Publicado: (2023)

Association of triglyceride-glucose index and neutrophil-to-lymphocyte ratio with coronary artery disease
por: Zhang, Bing, et al.
Publicado: (2023)

Associations of Modified Healthy Aging Index With Major Adverse Cardiac Events, Major Coronary Events, and Ischemic Heart Disease
por: Huang, Ninghao, et al.
Publicado: (2023)

Association of triglyceride-glucose index with major depressive disorder: A cross-sectional study
por: Jin, Man, et al.
Publicado: (2023)

The synergistic effect of the triglyceride-glucose index and serum uric acid on the prediction of major adverse cardiovascular events after coronary artery bypass grafting: a multicenter retrospective cohort study
por: Wu, Zhenguo, et al.
Publicado: (2023)

Predictive Effect of Triglyceride-Glucose Index on Adverse Prognostic Events in Patients with Type 2 Diabetes Mellitus and Ischemic Cardiomyopathy
por: Abuduaini, Baiheremujiang, et al.
Publicado: (2023)

The triglyceride-glucose index predicts peripheral artery disease complexity
por: DURAN KARADUMAN, Bilge, et al.
Publicado: (2020)

The predictive value of the triglyceride—glucose index for cardiovascular events in patients with coronary chronic total occlusion
por: Li, Yingkai, et al.
Publicado: (2022)

A promising tool: triglyceride–glucose index to stratify the risk of cardiovascular events in chronic kidney disease
por: Yildirim, Fatma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5de0vf40v30ug03755i4o84eeq